HUNTSMAN RONALD KIRK (Chairman & CEO) purchased 72.7% of their position (20K shares) of VIVOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/28/2022ACC: 0001493152-22-036727
DirectorOfficer10% Owner· Chairman & CEO
Since Dec 2020
+503.33K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
503.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$0.50
Trade value
$10K
% of position
72.7%
12/23/2022
27.50K→47.50K
Total
Net shares
+20K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2022 | P · Purchase | +20K | $0.50 | $10K | 72.7% | 27.50K | 47.50K |
| Total | +20K | $10K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
333.33K shares
Shares
+333.33K
Strike price
0.48
Held after
333.33K
Exercisable
—
12/23/2022
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
483.33K shares
Shares
+150K
Strike price
0.48
Held after
483.33K
Exercisable
—
12/23/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock333.33K shares | 12/23/2022 | A · Award | +333.33K | 0.48 | — | 333.33K |
| Stock Option (Right to Buy) Direct | Common Stock483.33K shares | 12/23/2022 | A · Award | +150K | 0.48 | — | 483.33K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.74M
Total
1.74M indirect1.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.74M | Indirect |
| Total | 1.74M | 1.74M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported